Genomenon: Funding, Investors & Team (Sep 2026)
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
Genomenon has raised $36.8M across 4 funding rounds on record, the most recent an undisclosed round of $6.0M announced in Jul 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genomenon Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Genomenon Funding Rounds
Genomenon raised $5.3M in a Series A announced in Mar 2021.
1 years later, a Series B of $20.0M was announced in Mar 2022.
2.2 years later, an undisclosed round of $5.5M was announced in May 2024.
2.2 years later, an undisclosed round of $6.0M was announced in Jul 2026.
Genomenon Investors
18 investors are recorded in total; the 5 named above are those the record identifies.
Genomenon Founders and Leadership Team
Contact details for the Genomenon team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Genomenon Funding Compared to Other Biotechnology Startups
Genomenon's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genomenon in Biotechnology and Ann Arbor
Companies Similar to Genomenon
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Genomenon Funding FAQs
What does Genomenon do?
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
How much funding has Genomenon raised?
Genomenon has raised $36.8M across 4 rounds on record. The most recent is an undisclosed round of $6.0M announced in Jul 2026.
When did Genomenon last raise funding?
Genomenon's most recent funding round on record is an undisclosed round of $6.0M, announced in Jul 2026.
Who has invested in Genomenon?
Investors on record for Genomenon include Michigan Rise, BroadOak Capital Partners, Spring Mountain Capital, University of Michigan, Beringea. FundedIQ records 18 investors in total.
Who founded Genomenon?
FundedIQ lists Mark J Kiel (Founder) at Genomenon.
Who is the CEO of Genomenon?
Mike Klein is listed as CEO at Genomenon.
Where is Genomenon headquartered?
Genomenon is based in Ann Arbor, Michigan, United States.
How many employees does Genomenon have?
Genomenon is in the 11-50 employee band.
When was Genomenon founded?
Genomenon was founded in 2014.
How does Genomenon's funding compare to other Biotechnology startups?
Genomenon's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Genomenon Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genomenon is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.